Helen Diller Family Comprehensive Cancer Center at UCSF

3:14

The Stephen and Nancy Grand Multiple Myeloma Translational Initiative at UCSF - Speeding the development of improved therapies for multiple myeloma patients. Learn how you can help!

3:10

Researchers at UC San Francisco are leading the way in identifying new pathways to treating many types of cancer. You can be a part of this movement by contributing directly to the UCSF Helen Diller Family Comprehensive Cancer Center. Give today at http://proj.at/1anxbig

1:40

Learn more about how UCSF's expert team is advancing cancer care and research worldwide.

3:36

Hormone therapy is a standard treatment for both early-stage and metastatic breast cancer. New studies show that extending the duration of treatment in post-menopausal women beyond the standard five years may reduce cancer recurrence and improve survival.

Hope S. Rugo, MD
Clinical Professor of Medicine; Director, Breast Oncology Clinical Trials Program
UCSF Helen Diller Family Comprehensive Cancer Center

1:47

Dr. Michael Rabow of the UCSF Helen Diller Family Comprehensive Cancer Center tells his palliative care moment.

4:05

One in 10-12 women with ovarian cancer has a hereditary cause of the ovarian cancer. Carefully collected three-generation pedigrees can help to determine which women should pursue genetic testing for hereditary causes of ovarian cancer, says Dr. Mary S. Beattie in this interview.

Mary S. Beattie, MD
Associate Clinical Professor of Medicine; Director, Clinical Research, UCSF Cancer Risk Program
UCSF Helen Diller Family Comprehensive Cancer Center

2:26

UCSF Radiologist Dr Bonnie Joe describes breast MRI and mammography images and how her team can turn a non-diagnostic exam into a diagnostic exam.

0:00

John Shoemaker talks about how he chose active surveillance to treat his prostate cancer at the UCSF Helen Diller Family Comprehensive Cancer Center. Read more about Shoemaker at http://www.ucsfhealth.org/patients/shoemaker_john/.

Advertisement